IDO‐1, KYNU, PAPP‐A, and IL‐1B were not upregulated in CEF‐CM‐treated CAFs, suggesting that CEFs do not amplify pre‐existing CAF function, but that newly differentiated CEFs can promote tumor progression. The gene discussed is IDO1; the disease is neoplasm.